Jennifer Kim
Stock Analyst at Cantor Fitzgerald
(0.44)
# 2463
Out of 5,333 analysts
47
Total ratings
32.50%
Success rate
-4.11%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BLTE Belite Bio | Reiterates: Overweight | n/a | n/a | n/a | 4 | Mar 18, 2025 | |
INSM Insmed | Reiterates: Overweight | n/a | n/a | n/a | 8 | Feb 20, 2025 | |
FBIO Fortress Biotech | Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
EYPT EyePoint Pharmaceuticals | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
ALLK Allakos | Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | n/a | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.67 | 198.51% | 2 | Aug 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 14 | 4.17 | 235.73% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 | 3.29 | 903.04% | 2 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 5 | 1.6 | 181.25% | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 100 | 1.25 | 7900% | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 56 | n/a | n/a | 2 | Mar 17, 2022 |